About The Report
Ultrasound-Guided Breast Biopsy Market Size and Share Forecast Outlook 2025 to 2035
The Ultrasound-Guided Breast Biopsy Market is estimated to be valued at USD 907.0 million in 2025 and is projected to reach USD 1958.1 million by 2035, registering a compound annual growth rate (CAGR) of 8.0% over the forecast period.
Quick Stats for Ultrasound-Guided Breast Biopsy Market
- Ultrasound-Guided Breast Biopsy Market Industry Value (2025): USD 907.0 million
- Ultrasound-Guided Breast Biopsy Market Forecast Value (2035): USD 1958.1 million
- Ultrasound-Guided Breast Biopsy Market Forecast CAGR: 8.0%
- Leading Segment in Ultrasound-Guided Breast Biopsy Market in 2025: Core needle (CN) ultrasound-guided breast biopsy (49.6%)
- Key Growth Region in Ultrasound-Guided Breast Biopsy Market: North America, Asia-Pacific, Europe
- Top Key Players in Ultrasound-Guided Breast Biopsy Market: Hologic, Medsurge, Ethicon Endo Surgery, Galini, Leica Biosystems, Becton and Dickinson Company, Cook Medical Incorporated, Argon Medical Devices
Rationale for Segmental Growth in the Ultrasound-Guided Breast Biopsy Market
Market Overview
The ultrasound-guided breast biopsy market has been expanding steadily due to the growing emphasis on early detection of breast abnormalities and the increasing adoption of minimally invasive diagnostic procedures. Continuous advancements in ultrasound imaging technologies have improved the precision and efficiency of breast biopsies, reducing patient discomfort and procedure time.
Medical practitioners have preferred ultrasound guidance for its real-time visualization and ability to target suspicious lesions with greater accuracy. Rising breast cancer screening rates and heightened awareness of preventive healthcare have also contributed to an increase in biopsy procedures worldwide.
Healthcare systems have been actively investing in diagnostic imaging equipment and expanding breast care units to address the growing patient population. Looking ahead, market growth is expected to be supported by technological improvements in biopsy needles and the integration of artificial intelligence in ultrasound platforms. Segmental leadership is anticipated to remain with Core needle (CN) ultrasound-guided breast biopsy as the leading procedure and Hospitals as the primary end user for these diagnostic services.
Segmental Analysis
The market is segmented by Procedure and End User and region. By Procedure, the market is divided into Core needle (CN) ultrasound-guided breast biopsy, Fine needle aspiration (FNA) ultrasound-guided breast biopsy, Vacuum-assisted device (VAD) ultrasound-guided breast biopsy, and Wire localization ultrasound-guided breast biopsy. In terms of End User, the market is classified into Hospitals, Clinics, Diagnostics Laboratories, and Others. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The market is segmented by Procedure and End User and region. By Procedure, the market is divided into Core needle (CN) ultrasound-guided breast biopsy, Fine needle aspiration (FNA) ultrasound-guided breast biopsy, Vacuum-assisted device (VAD) ultrasound-guided breast biopsy, and Wire localization ultrasound-guided breast biopsy. In terms of End User, the market is classified into Hospitals, Clinics, Diagnostics Laboratories, and Others. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
Insights into the Procedure Segment: Core needle (CN) ultrasound-guided breast biopsy
The Core needle (CN) ultrasound-guided breast biopsy segment is projected to hold 49.6% of the market revenue in 2025, sustaining its position as the most preferred procedure type. This segment’s growth has been supported by the clinical effectiveness of core needle biopsy in obtaining adequate tissue samples for accurate pathological assessment.
Clinicians have relied on this procedure for its balance of diagnostic precision and minimal invasiveness, making it suitable for both benign and malignant lesion evaluations. Compared to other biopsy methods, core needle biopsy has provided quicker recovery times and reduced the need for surgical intervention.
The procedure has gained acceptance in outpatient and day-care settings due to its safety profile and cost-efficiency. With increasing screening initiatives and patient awareness driving early detection efforts, the Core needle (CN) ultrasound-guided breast biopsy segment is expected to remain at the forefront of breast biopsy procedures.
Insights into the End User Segment: Hospitals
The Hospitals segment is projected to account for 52.3% of the ultrasound-guided breast biopsy market revenue in 2025, establishing itself as the largest end user. Growth in this segment has been driven by the comprehensive diagnostic and therapeutic services offered by hospitals, which have made them the preferred choice for breast health evaluations.
Hospitals have been equipped with advanced ultrasound imaging systems and multidisciplinary breast care teams, enabling them to provide accurate biopsy services and timely treatment planning. Patients have consistently sought hospital-based diagnostics due to the availability of specialized radiologists and pathologists, ensuring reliable results.
Additionally, healthcare policies in many regions have prioritized hospital settings for early breast cancer detection programs and screening initiatives. As the prevalence of breast cancer continues to rise, hospitals are expected to maintain their leadership in biopsy procedure volume, supported by their integrated care approach and expanding diagnostic capabilities.
Which are Factors Spurring Demand in the Ultrasound-Guided Breast Biopsy Market?
Ultrasound-guided breast biopsy is comparatively less invasive than other surgical biopsies, it leaves little scarring and can be performed in a limited time frame. These factors, combined together, will increase the adoption rate of ultrasound-guided breast biopsy.
In addition to this, ultrasound-guided breast biopsy does not carry ionizing radiation and provides faster results. It is also less expensive and has shorter recovery period. On the back of these factors, demand in the market is projected to increase at a considerable pace over the forecast period.
Which are Factors Hindering the Growth in the Ultrasound-Guided Breast Biopsy Market?
Ultrasound-guided breast biopsy also has certain aspects that impede sales in the market. The ultrasound-guided breast biopsy is known to carry a risk of bleeding that forms hematoma because of which consumers might reject this method of biopsy. This in turn hampers the growth in the ultrasound-guided breast biopsy market.
Furthermore, other factors such as discomfort experienced by patients during biopsy and the cost of an ultrasound machine might also impede the growth in ultrasound-guided breast biopsy market over the forecast period.
What is the Demand Outlook of the Ultrasound-Guided Breast Biopsy Market in North America?
The American Cancer Society’s estimates for the year 2025 states that there will be 287,850 new cases of breast cancer, with 43,250 deaths. This rising prevalence of breast cancer along with an increasingly alert population may increase the demand for ultrasound-guided breast biopsy in North America.
Thus, ultrasound-guided breast biopsy market in North America is expected to exhibit a significant growth rate for the forecast period. Advancing technologies, high investments in the healthcare sector, and increasing production of new and improved imaging technologies will augment sales in the ultrasound-guided breast biopsy market in North America.
How is Surging Awareness Of Breast Cancer Propelling Sales of Ultrasound-Guided Breast Biopsy in Asia Pacific?
ncreasing awareness regarding early diagnosis and treatment of breast cancer among individuals across Asia Pacific is expected to create opportunities for growth in the market. Owing to rising amount of campaigns about breast cancer, majority of the population is aware about diagnosis and treatment methods for breast cancer. This is expected to boost the Asia Pacific ultrasound-guided breast biopsy market over the forecast period.
Market Competition
Leading players operating in the global ultrasound-guided breast biopsy market include Hologic, Inc., Medsurge Ind Private Limited among others.
Key companies in the market are engaged in developing their portfolio of breast biopsy products and accessories. The focus is also on contracts and partnerships to launch insight driven products, product commercialization and pipeline development in order to strengthen market position.
Report Scope
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2020 to 2024 |
| Forecast Period | 2025 to 2035 |
| Quantitative Units | Revenue in million and CAGR from 2025 to 2035 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
Procedure, End User, Region |
| Countries Covered | North America (USA, Canada), Latin America (Mexico, Brazil), Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg), Eastern Europe (Russia, Poland), Asia-Pacific Excluding Japan(China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC Countries, South Africa, North Africa)
|
| Key Companies Profiled | Hologic Inc; Medsurge Ind Private Limited |
| Customization | Available Upon Request |
Key Segments Profiled in the Ultrasound-Guided Breast Biopsy Market Survey
By Procedure:
- Fine needle aspiration (FNA) ultrasound-guided breast biopsy
- Core needle (CN) ultrasound-guided breast biopsy
- Vacuum-assisted device (VAD) ultrasound-guided breast biopsy
- Wire localization ultrasound-guided breast biopsy
By End User:
- Hospitals
- Clinics
- Diagnostics Laboratories
- Others
By Region:
- North America (USA, Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Russia, Poland)
- Asia-Pacific Excluding Japan(China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, South Africa, North Africa)
Frequently Asked Questions
How big is the ultrasound-guided breast biopsy market in 2025?
The global ultrasound-guided breast biopsy market is estimated to be valued at USD 907.0 million in 2025.
What will be the market size for the ultrasound-guided breast biopsy market in 2035?
It is projected to reach USD 1,958.1 million by 2035.
How much will be the CAGR of the ultrasound-guided breast biopsy market between 2025 and 2035?
The market is expected to grow at a 8.0% CAGR between 2025 and 2035.
What are the key product types in the ultrasound-guided breast biopsy market?
The key product types are core needle (cn) ultrasound-guided breast biopsy, fine needle aspiration (fna) ultrasound-guided breast biopsy, vacuum-assisted device (vad) ultrasound-guided breast biopsy and wire localization ultrasound-guided breast biopsy.
Which hospitals segment is expected to dominate the ultrasound-guided breast biopsy market in 2025?
hospitals segment is expected to dominate with a 52.3% industry share in 2025.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2020-2024 and Forecast, 2025-2035
- Historical Market Size Value (USD Million) Analysis, 2020-2024
- Current and Future Market Size Value (USD Million) Projections, 2025-2035
- Y-o-Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2020-2024 and Forecast 2025-2035
- Global Market Analysis 2020-2024 and Forecast 2025-2035, By Procedure
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Procedure , 2020-2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Procedure , 2025-2035
- Core needle (CN) ultrasound-guided breast biopsy
- Fine needle aspiration (FNA) ultrasound-guided breast biopsy
- Vacuum-assisted device (VAD) ultrasound-guided breast biopsy
- Wire localization ultrasound-guided breast biopsy
- Core needle (CN) ultrasound-guided breast biopsy
- Y-o-Y Growth Trend Analysis By Procedure , 2020-2024
- Absolute $ Opportunity Analysis By Procedure , 2025-2035
- Global Market Analysis 2020-2024 and Forecast 2025-2035, By End User
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User, 2020-2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2025-2035
- Hospitals
- Clinics
- Diagnostics Laboratories
- Others
- Hospitals
- Y-o-Y Growth Trend Analysis By End User, 2020-2024
- Absolute $ Opportunity Analysis By End User, 2025-2035
- Global Market Analysis 2020-2024 and Forecast 2025-2035, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2020-2024
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025-2035
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- USA
- Canada
- Mexico
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- Latin America Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- Western Europe Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- Eastern Europe Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- East Asia Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- China
- Japan
- South Korea
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- South Asia and Pacific Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- Middle East & Africa Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025-2035
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Procedure
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Procedure
- By End User
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Canada
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Mexico
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Brazil
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Chile
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Germany
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- UK.
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Italy
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Spain
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- France
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- India
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- China
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Japan
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- South Korea
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Russia
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Poland
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Hungary
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- South Africa
- Pricing Analysis
- Market Share Analysis, 2024
- By Procedure
- By End User
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Procedure
- By End User
- Competition Analysis
- Competition Deep Dive
- Hologic
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Medsurge
- Ethicon Endo Surgery
- Galini
- Leica Biosystems
- Becton and Dickinson Company
- Cook Medical Incorporated
- Argon Medical Devices
- Hologic
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2020-2035
- Table 2: North America Market Value (USD Million) Forecast by Country, 2020-2035
- Table 3: Latin America Market Value (USD Million) Forecast by Country, 2020-2035
- Table 4: Western Europe Market Value (USD Million) Forecast by Country, 2020-2035
- Table 5: Eastern Europe Market Value (USD Million) Forecast by Country, 2020-2035
- Table 6: East Asia Market Value (USD Million) Forecast by Country, 2020-2035
- Table 7: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020-2035
- Table 8: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020-2035
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2020–2035
- Figure 3: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
- Figure 4: Global Market Y-o-Y Growth Comparison by Region, 2025–2035
- Figure 5: Global Market Attractiveness Analysis by Region
- Figure 6: North America Market Incremental $ Opportunity, 2025–2035
- Figure 7: Latin America Market Incremental $ Opportunity, 2025–2035
- Figure 8: Western Europe Market Incremental $ Opportunity, 2025–2035
- Figure 9: Eastern Europe Market Incremental $ Opportunity, 2025–2035
- Figure 10: East Asia Market Incremental $ Opportunity, 2025–2035
- Figure 11: South Asia and Pacific Market Incremental $ Opportunity, 2025–2035
- Figure 12: Middle East & Africa Market Incremental $ Opportunity, 2025–2035
- Figure 13: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 14: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 15: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 16: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 17: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 18: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 19: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 20: Global Market – Tier Structure Analysis
- Figure 21: Global Market – Company Share Analysis
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
